Pictured: Kris was left paralyzed from the neck down after a car accident, but has regained significant upper body strength since receiving a stem cell treatment.


Californians forStem Cell Research,
Treatments & Cures

Proposition 14 continues vital funding to find treatments and cures for life-threatening diseases and conditions that affect someone in nearly half of all California families – such as cancer, Alzheimer’s, and diabetes.

Pictured: Kris was left paralyzed from the neck down after a car accident, but has regained significant upper body strength since receiving a stem cell treatment.

Over 80 Leading Patient Advocate Groups
urge YES on Prop 14:

Prop 14 Makes economic sense!

  • No state payments on bonds for the first five years
  • Provides economic stimulus for COVID-19 recovery
  • Average state costs of only $5 per person, per year
  • New treatments and cures could significantly reduce healthcare costs


Rosie was diagnosed with Retinitis Pigmentosa.

In 2015, she volunteered for a stem cell clinical trial sponsored by California’s stem cell institute. Her vision began improving, and 17 months later, she could see her children, make out her own handwriting, and look into her own mother’s eyes.

- Rosie Barrero
Read More

Evangelina was cured of Bubble Baby disease.

Evangelina was one of the first to receive a groundbreaking new stem cell therapy at UCLA, which modified her own blood stem cells in order to repair her immune system.

- Evangelina Padilla-Vaccaro
Read More

RecentNews on Stem Cell Research

Research Scientist

Catriona Jamieson, M.D., Ph.D.
Director, Sanford Stem Cell Clinical Center
Deputy Director, Moores Cancer Center, UCSD

"California’s stem cell research institute provided critical early funding that allowed us to develop two highly effective cancer treatments that received FDA approval in 2018 and 2019."

*Titles are for identification purposes only

Dr. John Zaia
Director, Center for Gene Therapy, City of Hope

"We could be on the brink of medical discoveries that could save the lives of patients impacted by COVID-19 and other diseases, and this research simply would not be possible without the initial investment Californians made in the state’s stem cell program in 2004."

*Titles are for identification purposes only

Dr. Joseph Wu
Director, Stanford Cardiovascular Institute

"As a member of the medical community on the frontlines, watching how currently incurable diseases, conditions and injuries impact families every day, I know how critically important it is to continue to conduct research that can provide real hope to the millions of Californians who need it most."

*Titles are for identification purposes only

Antoni Ribas, M.D., Ph.D.
President, American Association for Cancer Research

"We must seize all opportunities to support advancements in medicine that could potentially save the lives of Californians battling cancer and other diseases, and we have that opportunity before us with this patient-centric initiative."

*Titles are for identification purposes only

Aaron J. Kowalski, Ph.D.
President, JDRF International

"Passing Proposition 14 will help further advance promising research, develop new treatment opportunities and provide hope for cures for people with diabetes and other chronic diseases."

*Titles are for identification purposes only

Phillip A. Pizzo, M.D.
Dean, Stanford Medical School, 2001-2012

"California has become the global leader in stem cell biology and regenerative medicine research leading to extraordinary scientific discoveries and innovations that are now being translated into an increasing number of promising clinical trials that offer hope to individuals with serious and in some cases catastrophic diseases."

*Titles are for identification purposes only

David A. Brenner, M.D.
Vice Chancellor
Health Sciences, UC San Diego

"Stem cell therapy represents our best opportunity to treat diseases that currently are untreatable, such as neurodegenerative diseases. Proposition 14 will enable California to continue to lead the world in developing stem cell therapy."

*Titles are for identification purposes only

Sidney Golub, Ph.D.
Professor Emeritus
Director, UCI Stem Cell Research Center,

"From the very start of the California stem cell program, the research it has supported has adhered to stringent ethical standards. All participating institutions have detailed and careful oversight programs to make sure that these clinical studies have the best chance of success and are as safe as possible."

*Titles are for identification purposes only